Masako Ohno

1.0k total citations
22 papers, 797 citations indexed

About

Masako Ohno is a scholar working on Molecular Biology, Pharmacology and Spectroscopy. According to data from OpenAlex, Masako Ohno has authored 22 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Pharmacology and 6 papers in Spectroscopy. Recurrent topics in Masako Ohno's work include Pharmacogenetics and Drug Metabolism (10 papers), Analytical Chemistry and Chromatography (6 papers) and Tuberculosis Research and Epidemiology (3 papers). Masako Ohno is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Analytical Chemistry and Chromatography (6 papers) and Tuberculosis Research and Epidemiology (3 papers). Masako Ohno collaborates with scholars based in Japan, Australia and Somalia. Masako Ohno's co-authors include Junichi Azuma, Isamu Yamamoto, Soichiro Yokota, Yasushi Fujio, Ryuji Kubota, Tsuyoshi Fukuda, Takayuki Nagai, Kazunari Tsuyuguchi, Tetsuya Takashima and Ichiro Kawase and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biophysical Journal and Journal of Chromatography A.

In The Last Decade

Masako Ohno

22 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masako Ohno Japan 13 491 204 191 185 142 22 797
Anima Ghosal United States 16 446 0.9× 165 0.8× 273 1.4× 224 1.2× 121 0.9× 28 946
Tian J. Yang United States 15 721 1.5× 157 0.8× 365 1.9× 314 1.7× 96 0.7× 28 1.2k
H. Heidemann Germany 16 374 0.8× 188 0.9× 292 1.5× 106 0.6× 115 0.8× 48 979
Huy Riêm Ha Switzerland 16 504 1.0× 258 1.3× 482 2.5× 246 1.3× 93 0.7× 21 1.3k
Kari T Kivist Germany 8 410 0.8× 235 1.2× 287 1.5× 139 0.8× 160 1.1× 8 861
Bryan A. Ward United States 7 677 1.4× 450 2.2× 392 2.1× 233 1.3× 101 0.7× 8 1.4k
Justin D. Lutz United States 16 294 0.6× 154 0.8× 219 1.1× 252 1.4× 63 0.4× 21 838
F A deLuna United States 15 166 0.3× 218 1.1× 292 1.5× 164 0.9× 108 0.8× 24 844
Brian Ethell United Kingdom 16 458 0.9× 81 0.4× 299 1.6× 376 2.0× 69 0.5× 26 1.1k
Caroline A. Lee United States 19 691 1.4× 166 0.8× 590 3.1× 277 1.5× 121 0.9× 27 1.4k

Countries citing papers authored by Masako Ohno

Since Specialization
Citations

This map shows the geographic impact of Masako Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Ohno more than expected).

Fields of papers citing papers by Masako Ohno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Ohno. The network helps show where Masako Ohno may publish in the future.

Co-authorship network of co-authors of Masako Ohno

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Ohno. A scholar is included among the top collaborators of Masako Ohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Ohno. Masako Ohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohno, Masako, Shinpei Nonen, Sachiko Hirobe, et al.. (2019). Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients. European Journal of Clinical Pharmacology. 75(7). 901–911. 7 indexed citations
2.
Matsumoto, Tomoshige, Masako Ohno, & Junichi Azuma. (2014). Future of Pharmacogenetics-Based Therapy for Tuberculosis. Pharmacogenomics. 15(5). 601–607. 31 indexed citations
3.
4.
Ohno, Masako, Akiko Yamamoto, Masanobu Funamoto, et al.. (2009). Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients. European Journal of Clinical Pharmacology. 65(11). 1097–1103. 48 indexed citations
5.
Kubota, Ryuji, et al.. (2007). Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2. European Journal of Clinical Pharmacology. 63(10). 927–933. 33 indexed citations
6.
Nakamura, Naoko, Keiko Ito, Kouji Hashimoto, et al.. (2007). Determination of single nucleotide polymorphisms in N-acetyltransferase2 gene using an electrochemical DNA chip and an automated DNA detection system.. PubMed. 55(3). 216–23. 2 indexed citations
7.
Ohno, Masako, et al.. (2004). The elution profile of immobilized liposome chromatography: determination of association and dissociation rate constants. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1665(1-2). 167–176. 3 indexed citations
8.
Hu, Wenzhi, Paul R. Haddad, Kazuhiko Tanaka, et al.. (2003). Creation and characteristics of phosphatidylcholine stationary phases for the chromatographic separation of inorganic anions. Journal of Chromatography A. 997(1-2). 237–242. 16 indexed citations
9.
Fukuda, Tsuyoshi, Shinya Onishi, Shuichi Fukuen, et al.. (2003). CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers. The Pharmacogenomics Journal. 4(1). 34–39. 41 indexed citations
10.
Hidai, Chiaki, Masako Ohno, Hiromi Kazama, et al.. (2003). Specific regulation of nucleocytoplasmic distribution of poly(C)-binding protein gene mRNA in mouse development. Biochemical and Biophysical Research Communications. 309(2). 339–343. 3 indexed citations
11.
12.
Hu, Wenzhi, Paul R. Haddad, Kiyoshi Hasebe, et al.. (2002). Use of a Biomimetic Chromatographic Stationary Phase for Study of the Interactions Occurring between Inorganic Anions and Phosphatidylcholine Membranes. Biophysical Journal. 83(6). 3351–3356. 14 indexed citations
13.
Uejima, Etsuko, Kyôko Takahashi, Koichi Takahashi, et al.. (2002). Microsomal Enzyme Induction and Clinical Aggravation of Porphyria: The Evaluation of Human Urinary 6β‐Hydroxycortisol/Cortisol Ratio as the Index of Hepatic CYP3A4 Activity. The Journal of Clinical Pharmacology. 42(12). 1374–1379. 6 indexed citations
14.
15.
Ohno, Masako, Ichiro Yamaguchi, Tomoaki Fukuda, et al.. (2000). Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.. PubMed. 4(3). 256–61. 188 indexed citations
16.
Ohno, Masako, et al.. (2000). Circadian variation of the urinary 6β-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity. European Journal of Clinical Pharmacology. 55(11-12). 861–865. 63 indexed citations
17.
Ohno, Masako, et al.. (2000). Specific determination of urinary 6β-hydroxycortisol and cortisol by liquid chromatography–atmospheric pressure chemical ionization mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 746(1). 95–101. 32 indexed citations
18.
Fukuda, Tsuyoshi, Isamu Yamamoto, Yuko Nishida, et al.. (1999). Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers. British Journal of Clinical Pharmacology. 47(4). 450–453. 77 indexed citations
19.
Zhou, Qian, et al.. (1999). CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin. European Journal of Clinical Pharmacology. 55(1). 43–47. 18 indexed citations
20.
Ito, Masayoshi, et al.. (1979). The Synthesis and Characterisations of Retinoidal 3(2H)-Furanones. Heterocycles. 12(4). 505–505. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anima Ghosal Breakdown of academic impact, for papers by Tian J. Yang Breakdown of academic impact, for papers by H. Heidemann Breakdown of academic impact, for papers by Huy Riêm Ha Breakdown of academic impact, for papers by Kari T Kivist Breakdown of academic impact, for papers by Bryan A. Ward Breakdown of academic impact, for papers by Justin D. Lutz Breakdown of academic impact, for papers by F A deLuna Breakdown of academic impact, for papers by Brian Ethell Breakdown of academic impact, for papers by Caroline A. Lee
Rankless by CCL
2026